CYSTARAN

Leadiant Biosciences, Inc.

Application Filed: 2010-07-28

Trademark Application Details

Status

702

Live/Registered

SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Research	OneLook Acronym Finder
Serial Number	85095017
Registration Number	4407365
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	MICHAEL N. MERCANTI
Attorney Docket Number	2108-1019TMA
Law Office Assigned	L70
Employee Name	PAPPAS, MATTHEW JAMES

Timeline

2010-07-28	Application Filed
2011-01-11	Published for Opposition
2013-05-28	Date of First Use
2013-09-24	Trademark Registered
2019-09-03	Location: TMEG LAW OFFICE 107
2019-09-03	Status: Live/Registered
2019-11-14	Transaction Date

Trademark Applicants & Owners

Owner:	LEADIANT BIOSCIENCES, INC.
Address	9841 WASHINGTONIAN BLVD SUITE 500 GAITHERSBURG NV 20878
Legal Entity Type	Corporation
Legal Entity State	NV

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

MICHAEL N. MERCANTI
LUCAS & MERCANTI, LLP
30 BROAD STREET, 21st FLOOR
NEW YORK, NY 10004

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Eye drops and medicated eye drops

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2010-07-31	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2010-08-02	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2010-11-10	3 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2010-11-11	4 CNSA P:
ASSIGNED TO LIE	2010-12-06	5 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2010-12-06	6 PREV O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2011-01-11	7 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2011-01-11	8 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2011-03-08	9 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2011-08-04	10 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2011-08-04	11 EXT1 S:
EXTENSION 1 GRANTED	2011-08-04	12 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2011-08-06	13 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2012-02-13	14 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2012-03-08	15 AITU A:Allowance for Publication
EXTENSION 2 FILED	2012-02-13	16 EXT2 S:
EXTENSION 2 GRANTED	2012-03-08	17 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2012-03-09	18 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2012-08-29	19 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2012-08-29	20 EXT3 S:
EXTENSION 3 GRANTED	2012-09-04	21 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2012-09-05	22 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2013-03-04	23 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2013-03-04	24 EXT4 S:
EXTENSION 4 GRANTED	2013-03-06	25 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-03-07	26 EXRA E:E-Mail
TEAS STATEMENT OF USE RECEIVED	2013-08-07	27 EISU I:Incoming Correspondence
USE AMENDMENT FILED	2013-08-07	28 IUAF S:
STATEMENT OF USE PROCESSING COMPLETE	2013-08-08	29 SUPC I:Incoming Correspondence
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	2013-08-09	30 CNPR P:
LAW OFFICE REGISTRATION REVIEW COMPLETED	2013-08-16	31 REGV O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED	2013-08-17	32 SUNA E:E-Mail
REGISTERED-PRINCIPAL REGISTER	2013-09-24	33 R.PR A:Allowance for Publication
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2014-03-19	34 TCCA I:Incoming Correspondence
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED	2018-09-24	35 REM1 E:E-Mail
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2019-06-26	36 ASGN I:Incoming Correspondence
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY	2019-07-24	37 ASCK I:Incoming Correspondence
TEAS SECTION 8 & 15 RECEIVED	2019-07-24	38 E815 I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2019-09-03	39 APRE A:Allowance for Publication
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.	2019-09-03	40 C15A O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED	2019-09-03	41 NA85 E:E-Mail
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED	2022-09-24	42 REM2 E:E-Mail
TEAS SECTION 8 & 9 RECEIVED	2023-06-22	43 E89R I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2023-12-16	44 APRE A:Allowance for Publication
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED	2023-12-16	45 89AG O:Outgoing Correspondence
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)	2023-12-16	46 RNL1 Q:
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED	2023-12-16	47 NA89 E:E-Mail

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
CYSTARAN 85095017 4407365 Live/Registered	LEADIANT BIOSCIENCES, INC. 2010-07-28
CYSTARAN 85089255 not registered Dead/Abandoned	Sigma-Tau Pharmaceuticals, Inc. 2010-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.